Objectives Monocyte chemoattractant protein (MCP)-1 and macrophage inflammatory protein (MIP)-loc exhibit chemotactic activity toward macrophages/monocytes and induce the production of inflammatory cytokines affecting granuloma formation. Recently, a single nucleotide polymorphism (SNP) in the MCP-1 distal regulatory region and a dinucleotide repeat in the MIP-1Agene promoter region were identified. Weinvestigated the relationships between the polymorphisms and susceptibility to sarcoidosis, clinical manifestations, and BALFfindings of sarcoidosis. Methods The polymorphisms of the MCP-1and MIP-1A genes in 118 patients with sarcoidosis and 145 healthy control subjects were examined. The MCP-1 polymorphism was genotyped by a PCR-restriction fragment length polymorphism method and the MIP-1Agenotype was determined using PCR. Results No significant difference in the genotype distribution or in the allele frequency between the patients and control subjects was observed. Wefound no relationship between the polymorphisms and the serum ACElevel, organ involvement, roentgenographic stages, or deterioration in chest radiographs during the follow-up. A significant difference in the absolute counts ofAMsin BALFof 51 patients amongthe genotypes of the MCP-1gene was found (p=0.048). The AMcounts in BALF of the G/A and G/G genotypes were significantly increased compared with that of the A/A genotype (p<0.05). Conclusion The polymorphisms of the MCP-1and MIP-1Agenes do not play a substantial role in genetic predisposition for sarcoidosis or in clinical manifestations of sarcoidosis in this Japanese population. The MCP-1 SNP might be related to the recruitment of monocytes/macrophages to the alveolar spaces in sarcoidosis. (Internal Medicine 41: 813-818, 2002) 
Introduction
Sarcoidosis is a systemic granulomatous disorder of unknown etiology involving multiple organs ( 1 , 2) . Sarcoid granuloma typically shows a center of epithelioid cells surrounded by CD4+ lymphocytes, some CD8+ lymphocytes, giant cells, and mature macrophages. In the affected organs, activated T cells and macrophagesrelease a numberof cytokines that provide the stimulus for progress toward the granuloma formation and, in some cases, to fibrosis. The recruitment of macrophages and T cells into the affected organ is thought to be an important step in the development of sarcoidosis. Monocytechemoattractant protein (MCP)-l and macrophage inflammatory protein (MlP)-la are members of the C-C chemokine supergene family (3, 4) . MCP-1 is a monocyte-specific chemotactic factor produced by a wide variety of cell types, including monocytes, fibroblasts, vascular endothelial cells, and smooth muscle cells. MIP-loc is produced by appropriately stimulated T cells, alveolar and peritoneal macrophages, neutrophils, monocytes, airway epithelial cells, and fibroblasts, and has been shownto activate mast cells and basophils to be chemotactic for T cells and monocytes. Both chemokines contribute to acute and cellular immune tissue responses via recruitment and activation of macrophages and T cells inducing the production of inflammatory cytokines which affect granuloma formation (5) (6) (7) (8) . In sarcoidosis, the elevation of the MCP-1 and MIP-l oc levels in bronchoalveolar lavage fluid (BALF) and the up-regulated expression of these chemokinesin macrophages in the affected organ have been shown (9, 10) . The human MCP-1gene transcript appears to be under the control of two distinct areas of the 5'-flanking region of the gene. Recently, two single nucleotide polymorphisms (SNPs) in the MCP-1distal regulatory region were identified and the SNPat position -2,5 18 was found to affect the transcriptiorial activity of the regulatory region, and monocyte MCP-1production (ll) . As for the MIP-1A gene, a biallelic dinucleotide microsatellite repeat was recently identified (12) . The repeat occurs within the promoter region, making it an ideal marker for association and linkage studies in inflammatory diseases. In the present study, we investigated the MCP-1and MIP-1A polymorphisms to clarify whether these polymorphisms are associated with susceptibility to sarcoidosis, clinical manifestations, and BALFfindings of sarcoidosis in a Japanese population.
Methods

Study Population
One hundred eighteen Japanese subjects with sarcoidosis were recruited from the clinic at the Niigata University Hospital. Sarcoidosis was diagnosed on the basis of the typical clinical features and the presence of epithelioid cell granulomas in biopsy specimens from the lung, skin, or lymph nodes. Fortyfour of the cases were menand 74 were women. The average age of the patients at diagnosis was 45.1 years with a range between 19 and 74 years. Regarding the roentgenographic stage of the patients at the first visit to our hospital, all but 10 had chest X-ray evidence of sarcoidosis, 59 with stage I, 41 with stage II, and eight with stage III disease.
As healthy controls, 145 unrelated healthy Japanese subjects were selected. They consisted of 84 men and 61 women with a meanage of40.9 years and a range between 21 and 70 years. They did not have any abnormalities based on physical examination, chest radiography, electrocardiogram (ECG), urinalysis, and routine laboratory blood testing. None were receiving medication at the time of the evaluation. All of the subjects in the study gave written informed consent for enrollment in the study and this study was approved by the Committee of Ethics, Niigata University. MCP1, MIP1A Polymorphisms in Sarcoidosis 5'-flanking region between nucleotide -1 ,8 17 and -2,746 relative to the major transcriptional start site defined by Ueda et al (13) . PCR was performed using denaturation at 94°C for 3 minutes, followed by 35 cycles at 94°C for 30 seconds, 60°C for 30 seconds, and 72°C for 30 seconds, and a final extension at 72°C for 3 minutes (DNAThermal Cycler 9600; Perkin Elmer-Cetus, Norwalk, CT). The PCR products were digested with 2.0 U ofPvu II (Takara-Shuzo, Kyoto) at 37°C for 2 hours, and run on a 1%ethidium bromide-agarose gel. Pvu II digested the 930 bp DNAsegment from G/G homozygous individuals into 708 and 222 bp fragments. DNAfrom A/A homozygous individuals was not cut with Pvu II. DNAfrom G/A hetorozygous individuals showed the expected fragments at 930, 708, and 222 bp (Fig. 1A ).
The PCRfor MIP-1A genotyping was performed using the following primers: 5'-TGT ATT TTT TTC CAT GCT TAG GGT TG-3', and 5'-TCA GTG GTT AAA AAA AGC AAG ATA CGA-3'. PCR cycles were as follows: 94°C for 3 minutes followed by 35 cycles each of94°C for 30 seconds, 53°C for 30 seconds, and 72°C for 30 seconds. A final extension step was carried out at 72°C for 3 minutes. The PCR products were visualized on a 12% polyacrylamide gel (acrylamide: bisacrylamide 19: 1) containing 10% glycerol stained with ethidium bromide (Fig. IB) . Samples that exhibited a single band were sequenced using the BigDye terminator cycle sequencing kit (PE; Applied Biosystems, Foster City, CA). Sequencing revealed a biallelic dinucleotide microsatellite repeat starting at position (-906) relative to the transcription site as described by Al-Sharif et al (12) .
Bronchoalveolar lavage
Bronchoscopy with BALwas performed on 5 1 patients with sarcoidosis with the informed consent of the patient as part of the routine clinical management of sarcoidosis as previously described (14) . Briefly, four 50-ml aliquots of 0.9% NaCl were instilled into the middle lobe. Each aliquot of infused fluid was immediately aspirated gently. The recovered BALFwas strained through three layers of gauze and kept on ice. Total cell counts were madeusing a hemocytometerand cell differentials were determinedafter cytocentrifugation and May-Giemsa staining.
Sta tistical analysis
The allele ratios and genotype distributions in sarcoidosis patients and control subjects, roentgenographic stages, and organ involvement amongthe three genotypes were analyzed with the chi-square test. The Fisher's exact test was also applied for comparison of small populations with expected values of less than five. The comparison of the serum level of ACE, and the percentage and the absolute count of alveolar macrophages (AMs) and lymphocytes in BALFamong the genotypes was tested with the Kruskal-Wallis rank test. The Mann-Whitney U-test was applied for comparison of the serum ACElevel and the percentage and absolute count of BALFcells between the genotypes. A p value <0.05 was considered significant.
Results
The allele frequencies and genotypes for the MCP-1and MIP-1A polymorphisms are summarized in genotypes. The genetic distribution was not different from that of all the 1 18 patients. Wetested the correlations between the genotypes and the percentage and the absolute count of AMs in BALF. Although no significant difference in the percentages ofAMswas observed amongthe genotypes, a significant difference in the absolute count ofAMswas found (p=0.048) (Fig. 2) . Comparing AMcounts between the genotypes, the AMcounts of the G/A and G/G genotypes were significantly higher than that of the A/A genotype (p=0.044 and p=0.012, respectively) ( Fig. 2B ). No significant difference in the absolute count ofAMswas observed between the G/A and G/G genotypes (p=0.69 1 ). There was no significant relationship with the percentage or the absolute count of AMsor lymphocytes for the MIP-1 genotypes (data not shown). I  II  I  I II  1 
MCP1, MIP1A Polymorphisms in Sarcoidosis Discussion
The present study showed a SNPat position -2,518 of the MCP-1 gene 5' flanking region and a biallelic dinucleotide microsatellite repeat polymorphismwithin the promoterregion of the MIP-1A gene in Japanese patients with sarcoidosis. Although we found no significant difference in the genotype or allele frequency between the patients and control subjects and no relationship between the polymorphisms and the serum ACE level, organ involvement, roentgenographic stages, or deterioration in chest radiographs during the follow-up, a significant difference in the absolute counts ofAMsin BALFamongthe genotypes for the MCP-1 gene was found. Our findings indicate that the polymorphisms do not play a substantial role in the genetic predisposition for sarcoidosis or in clinical manifestations of sarcoidosis in this Japanese population and that the MCP-1promoter SNPmight be related to the recruitment of monocytes/macrophages to alveolar spaces in sarcoidosis.
The current consensus regarding its pathogenesis is that sarcoidosis results from exposure of genetically susceptible hosts to particular environmental factors ( 1 5) . Some polymorphisms have been reported to be involved in the susceptibility to sarcoidosis, in disease severity and progression, or in disease prognosis (14, (16) (17) (18) . Up-regulated expression of MCP-1 in the affected organ of sarcoidosis has been shown (9, 19) . MCP-1 exhibits chemotactic activity toward monocytes/macrophages and induces the production of inflammatory cytokines affecting granuloma formation. Although the SNP of MCP-1 was not associated with susceptibility to the disease, the absolute counts ofAMs in BALFof the G/A and G/G genotypes were significantly increased compared with that of the A/A genotype in this sarcoidosis population. Rovin et al showed that a G allele at -2,5 18 affected the transcriptional activity of the distal regulatory region, and increased monocyte MCP-1 production (1 1). This SNPdoes not alter the known transcription factor binding sites of the MCP-1distal regulatory region, but may affect a previously unidentified site. The G allele at -2,5 18 might possibly enhance the binding specificity of this motif to an unknowntranscription factor resulting in an increase of the MCP-1expression. Individuals who carry the variant A allele might have decreased recruitment of monocytes, because of low MCP-1production. Another possible explanation for the association between the SNPand the increased AMcount in BALFcould be a linkage disequilibrium between this SNPand another as yet unknownfunctional mutation elsewhere in the MCP-1 sequence. The mechanistic details remain unclear, but our results suggest that the MCP-1gene SNPat -2,518 might play an important role in the recruitment of monocytes/macrophages to the alveolar spaces in sarcoidosis. The recruitment of macrophages and T cells into the affected organ is thought to be an important step in the development of sarcoidosis. Further studies will be needed to elucidate whether the SNPis associated with the detailed radiographic findings or pulmonary function tests. The serum and BALFMCP-1levels were significantly elevated in sarcoidosis patients compared with healthy controls (9, 20) . Studies to investigate the relationship between the MCP-1genotypes and MCP-1levels in serum and BALFare currently underway. Westudied 145 healthy Japanese individuals and found the G allele/A allele ratio was 0.71/0.29 in this population in contrast to 0.29/0.71 in a Caucasian population in a previous report (ll) . The SNP in the MCP-1promoter region was associated with the presence of cutaneous vasculitis amongpatients with SLE (21) and the presence and severity of asthma and increased eosinophil levels (22) . However, the racial heterogeneity of the SNPin the diseases has not been examined. It has been reported that MCP-1plays an important role in the production and development of various inflammatory diseases (23) (24) (25) . Further investigation of the general association of the SNP with other inflammatory diseases in Caucasians and in Asian groups is needed. In sarcoidosis, the MlP-la level in BALFwas elevated and a substantial expression of cell-associated MlP-l a was detected in the macrophages including both AMsand interstitial macrophages, and interstitial pulmonary fibroblasts by immunohistochemical analysis ( 10) . Al-Sharif et al identified a biallelic dinucleotide repeat within the promoter region of the MIP-1A gene (12) . The functional significance of dinucleotide repeat regions is being increasingly realized with respect to their influence on the DNAstructure, gene expression, and genomic (in)stability (26, 27) . The present findings showed no significant difference in the MIP-1A genotype between sarcoidosis patients and healthy controls and no association between the genotype and organ involvement. The MIP-1 a expression from mononuclear cells is stimulated in vitro by lipopolysaccharide and IL-1 (28) . The increased production of IL-1, TNF-oc or PDGFby AMsfrom patients may function in an autocrine or paracrine fashion to up-regulate the expression of MIP-1 a. Recently, novel SNPsat four sites within the MIP-1Agene and a relationship between one of the SNPsand atopic dermatitis were found in a Japanese population (29) . MIP-1a is involved in inflammation, wound healing and hematopoiesis (8, (30) (31) (32) . Study of the association of the SNPswith sarcoidosis and other diseases is necessary.
